COMMUNIQUÉS West-GlobeNewswire

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million
30/01/2025
Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) [...]
Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO®
30/01/2025
Saint Herblain (France), le 30 janvier 2025 – Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui la signature d’un nouveau contrat de $32.8 millions avec le [...]
SPR Announces Presentation of Four Abstracts Featuring the SPRINT® PNS System at NANS 2025
30/01/2025
CLEVELAND, Jan. 30, 2025 (GLOBE NEWSWIRE) -- SPR announces four featured abstracts that will be presented at the upcoming North American Neuromodulation Society (NANS) Annual Meeting in Orlando, January 29 – February 1 [...]
The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of Directors
30/01/2025
Dr. Blackman brings his singular experience as co-founder of Day One Biopharmaceuticals and a physician-scientist in pediatric neuro-oncology to the PBTF’s pediatric brain tumor community BOSTON, Jan. 30, 2025 (GLOBE [...]
Leading Laser Medicine Expert Dr. Rox Anderson Joins AVAVA™ Board of Directors
30/01/2025
WALTHAM, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a leader in the aesthetic energy device market, proudly announces the appointment of Dr. Rox Anderson, co-founder of AVAVA, to its Board of Directors. Widely [...]
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
30/01/2025
PHOENIX, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company focused on regenerative medicine, today announced promising initial data from [...]
PacBio Announces Appointment of Chris Smith to Board of Directors
30/01/2025
PacBio to leverage Chris' extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down. MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a [...]
Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics
30/01/2025
ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics Orion Corporation [...]
Niger becomes the first country in sub-Saharan Africa to eliminate the transmission of onchocerciasis
30/01/2025
DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, commonly known as river [...]
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
30/01/2025
WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, [...]
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
30/01/2025
European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting in non-surgical permanent contraception ATLANTA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq [...]
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
30/01/2025
SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
TOMI Environmental Reports Strong Start to 2025 with January Revenue Growth
30/01/2025
FREDERICK, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced positive [...]
Stereotaxis Announces First GenesisX Robotic System Order
30/01/2025
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has received the first order [...]
Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
30/01/2025
CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates ( [...]
Liberation Labs Closes $50.5 Million Convertible Note
30/01/2025
Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond, Indiana RICHMOND, Ind., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has closed [...]
Rentschler Biopharma announces strategic realignment of its global business operations
30/01/2025
LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its [...]
YuzuYello Named an Ad Age Best Place to Work 2025
28/01/2025
IPG Health agency honored with third recent noteworthy culture-focused award NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Yesterday, YuzuYello, an IPG Health company, announced that it has earned a top spot on Ad Age’s [...]
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
28/01/2025
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief [...]

Pages